Latest News

• share
• favorite_border

ROCKVILLE, MD – The Biophysical Society is pleased to announce the recipients of its 2025 Society Awards. These awards are very competitive in nature and are intended to recognize Society members for excellence in biophysics. The winners will be honored at the Society’s 69th Annual Meeting being held in Los Angeles, California from February 15-19, 2025.

• share
• favorite_border

Scientists at ORNL used neutrons to end a decades-long debate about an enzyme cancer uses. Their findings can support the design of an inhibitor that can target aggressive cancers.

• share
• favorite_border

Irvine, Calif., Sept. 24, 2024 — The University of California, Irvine has been ranked ninth among the nation’s public universities – and 33rd overall – on U.S. News & World Report’s 2024-25 list of “Best Colleges,” released today. This is the 10th consecutive year in which UC Irvine has placed in the top 10. The U.S. News & World Report rankings – now in their 40th year – assess the country’s bachelor’s degree-granting institutions on more than a dozen measures of academic quality.

• share
• favorite_border

ROCKVILLE, MD – The Biophysical Society is proud to announce its 2025 Society Fellows. This award honors the Society’s distinguished members who have demonstrated excellence in science and contributed to the expansion of the field of biophysics. The Fellows will be honored at the Biophysical Society’s 69th Annual Meeting, being held in Los Angeles, California from February 15-19, 2025.

• share
• favorite_border

Comprehensive gene panel testing, one of the exciting new tools in cancer diagnostics, warrants greater scrutiny — as does a federal program aimed at speeding up the review process for proposed new medical technologies. Those are conclusions of Yale medical experts who studied both and published a report in the Journal of the National Cancer Institute on Sept.

• share
• favorite_border

Three Mile Island, the nuclear power plant in Pennsylvania that’s been shuttered since 2019, could come back to life to meet Microsoft’s energy needs. ...

• share
• favorite_border

Vice President Kamala Harris may visit the US-Mexico border on Friday as her campaign looks to close the gap with former President Donald Trump on immigration. ...

• share
• favorite_border

The company said on Monday that this was its “best and final” offer, which would among many things boost general wages by 30% over four years. ...

• share
• favorite_border

Nebraska state Sen. Mike McDonnell announced Monday that he opposes efforts to change how the state allocates its electoral votes before the upcoming 2024 election. ...

• share
• favorite_border

Itchy skin can be irritating, especially an itch that doesn’t go away. There are many potential causes for itchy skin like common skin conditions such as eczema, shingles, hives, psoriasis, or bug bites, or it could be a sign of a contagious disease, like scabies or ringworm. While these causes could mean a visit to a board-certified dermatologist, there are options for self-care at home to provide itch relief.

• share
• favorite_border

Strong bones and joints are essential for overall quality of life. They enable us to perform daily tasks, participate in activities we enjoy and maintain independence as we age. For women going through menopause, preserving bone and joint health is particularly important, as the risk of osteoporosis and fractures increases significantly during this time.

• share
• favorite_border

The statewide policy clarifies expectations for heat safety modifications during sports, promotes communication and secure documentation for health-related information, and sets the minimum standard for access to health care services at events.

• share
• favorite_border

Two years and seven months into the invasion of Ukraine by Russian military forces, the attitudes of the Ukrainian people toward ending the war are reluctantly shifting. Virginia Tech international affairs expert Gerard Toal has researched Ukrainian public opinion for a decade. His most recent findings indicate that more Ukrainians have become open to entering into negotiations with Russia.

• share
• favorite_border

The uninsured rate in Missouri has dropped significantly, according to a new analysis by the Center for Advancing Health Services, Policy & Economics Research at Washington University in St. Louis.

• share
• favorite_border

Children’s Hospital Los Angeles cardiologist Jondavid Menteer, MD, was honored with the World Children’s Transplant Fund “WCTF for the Children Award.” The prestigious award recognized Dr. Menteer for 20 years of dedication and leadership in pediatric heart transplant at Children’s Hospital Los Angeles, which is home to the largest heart center for children in the Western U.S.

• share
• favorite_border

The Cancer Research Institute and the Kidney Cancer Association are collaborating on a new kidney cancer immunotherapy research grant.

• share
• favorite_border

Un raro trastorno de deterioro cognitivo hereditario conocido como Trastorno Relacionado con CSF1R (CSF1R-RD, por sus siglas en inglés) recibe su nombre debido a mutaciones en el gen CSF1R, descubierto por Mayo Clinic. La pérdida de memoria ocurre a medida que avanza la afección, mientras que los primeros síntomas incluyen cambios de personalidad, ansiedad, depresión y pérdida de inhibición. Las pruebas genéticas se han vuelto más ampliamente disponibles, pero no existe cura para la enfermedad.

• share
• favorite_border

Um transtorno raro de declínio cognitivo hereditário conhecido como Transtorno Relacionado ao CSF1R (CSF1R-RD, sigla em inglês) recebe o seu nome devido a mutações no gene CSF1R, descoberto pela Mayo Clinic. A perda de memória ocorre à medida que a condição avança, enquanto os primeiros sintomas incluem alterações de personalidade, ansiedade, depressão e perda de inibição. Os testes genéticos tornaram-se mais amplamente disponíveis, mas não há cura para a doença.

• share
• favorite_border

Mayo Clinic in Florida has received a grant from the National Institute of Neurological Disorders and Stroke (NIDS) to begin an innovative study that will provide hundreds of patients with amyotrophic lateral sclerosis (ALS) access to the experimental drug ibudilast over six months.